archTIS (ASX: AR9) expands US DoD quotation to 325,000 users as A$15m opportunity stays live

archTIS Limited (ASX: AR9) has provided an update on a potentially transformative United States Department of Defense enterprise-licensing opportunity, saying the requested scope has expanded from 121,000 users to as many as 325,000. The company has submitted an updated tiered quotation covering single and multi-year options after meetings with Department of Defense representatives and Copper River in Washington, with an indicative one-year annual value of approximately A$7.5 million to A$15 million. No binding contract, commencement date or final contract value has been announced.

The opportunity is large relative to archTIS. The company reported annual recurring revenue of A$15.1 million during Q3 FY26, meaning the upper end of the potential Department of Defense licensing value would roughly equal its entire reported ARR at that point. The A$7.5 million lower end would still equal almost half that recurring-revenue base.

AR9 closed at A$0.044 on August 28, unchanged for the session, with a market capitalisation of approximately A$21.3 million. The stock was trading near the bottom of its A$0.042 to A$0.175 52-week range and had declined roughly 76% over the preceding year. The August 31 update was issued before Monday’s complete trading session was available, so A$0.044 is the cleaner pre-announcement market reference.

How much has the potential US Department of Defense deployment expanded?

The latest quotation covers up to 325,000 users compared with the previous 121,000-user scope, representing an increase of approximately 204,000 users or 169%. Put differently, the maximum licensing population under discussion is now about 2.7 times the original scale.

That change is commercially important because enterprise cybersecurity software often carries high incremental margins once development and support infrastructure is established. A deployment across hundreds of thousands of defence users could therefore materially change archTIS’s recurring-revenue base if a contract is ultimately awarded.

The company says the technical pathway has already progressed through production testing. NC Protect completed 60 of 60 Warfighter Command production test cases in May, after which discussions moved further into commercial requirements. The Department of Defense subsequently requested revised pricing to reflect the larger potential user base and different contract-duration options.

None of those steps constitutes an award. A request for quotation is part of a procurement process and does not obligate the customer to proceed, purchase the maximum number of licences or accept the quoted commercial terms. That distinction is particularly important when the potential contract is so large relative to the supplier.

Why would a A$15 million contract be transformative for archTIS?

archTIS had a market capitalisation of roughly A$21.3 million before the update. A hypothetical A$15 million annual contract value would therefore equal about 70% of the company’s entire equity value, while even A$7.5 million would equal roughly 35%. Those ratios illustrate materiality rather than valuation because contract revenue, market capitalisation and profit are fundamentally different measures.

The opportunity is also unusually large against archTIS’s recent revenue base. Available financial data show trailing revenue around A$9.4 million, although the company’s reported ARR has already moved substantially higher as defence and software subscriptions expanded. A full-scale Department of Defense deployment could therefore produce a step-change in reported revenue once licences commence, depending on accounting treatment and timing.

That potential upside sits beside an important financial constraint. archTIS remains loss-making, with recent trailing data showing approximately A$6.5 million of cash, A$2.5 million of debt and negative operating cash flow. The company has therefore been investing ahead of profitable scale, making successful conversion of large recurring software opportunities strategically important rather than merely incremental.

What is archTIS selling beyond NC Protect licensing?

During the Washington meetings, archTIS also demonstrated its Trusted Data Integration platform to Department of Defense stakeholders. The platform is designed to bring sensitive or classified information from multiple sources into a governed environment while applying granular Zero Trust access policies determining which users can access specific data.

The company said that demonstration has led to further presentations with additional Department of Defense teams. That creates a potentially broader commercial pathway than the NC Protect licensing quotation alone because archTIS could participate in data-integration architecture as well as protecting information inside Microsoft environments.

The strategic opportunity is therefore two-layered. NC Protect represents a potentially very large enterprise licence, while Trusted Data Integration could create additional projects if the technology becomes embedded more deeply across defence information systems. Neither should be included as contracted revenue until formal awards are announced.

Why has AR9 fallen so sharply despite stronger recurring revenue?

archTIS shares were down approximately 76% over the preceding 52 weeks by August 28, leaving the stock near its annual low despite rapid ARR growth and continuing defence engagement.

Part of the tension comes from timing. Large government opportunities can remain commercially promising for long periods without producing signed contracts, while smaller software companies continue carrying staff, product-development and compliance expenses throughout the sales cycle. For investors, another demonstration or expanded quotation therefore has less value than an executable contract specifying licences, price, commencement and duration.

The balance between opportunity and certainty is particularly stark with the Department of Defense proposal. At its maximum A$15 million annual indication, the licence could be company-changing; at present, recognised value is zero because no award has been made. The market will likely continue applying a substantial probability discount until the procurement process reaches a binding stage.

That makes the next announcement binary in significance even if it is not binary in outcome. A meaningful contract could fundamentally alter archTIS’s revenue scale and recurring-revenue profile, while continued procurement delays would keep attention on cash consumption and the time required for the company’s larger defence pipeline to convert.